• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Tobacco Products

Reporting Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke Under Section 904(a)(3) of the Federal Food, Drug, and Cosmetic Act


 

March 2012

PDF
Draft Guidance for Industry: Reporting Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke Under Section 904(a)(3) of the Federal Food, Drug, and Cosmetic Act


 

This document, when finalized, will provide guidance on how companies can comply with the requirement to report on the quantities of harmful and potentially harmful constituents (HPHCs) in tobacco products.

FDA recognizes that industry may be unable to meet the deadline due to current testing limitations. In recognition of this, the draft guidance identifies 20 HPHCs from the full list of 93 HPHCs, for which testing methods are well established and widely available.  FDA intends to exercise enforcement discretion to require reporting about only these 20 constituents this year. 

The abbreviated list of 20 HPHCs is included in the draft guidance and listed below. 


 

Table 1. Abbreviated List of Harmful and Potentially Harmful Constituents

 

HPHCs in Cigarette Smoke

HPHCs in Smokeless Tobacco

HPHCs in Roll-your-own Tobacco and Cigarette Filler

Acetaldehyde

Acetaldehyde

Ammonia

Acrolein

Arsenic

Arsenic

Acrylonitrile

Benzo[a]pyrene

Cadmium

4-Aminobiphenyl

Cadmium

Nicotine (total)

1-Aminonaphthalene

Crotonaldehyde

NNK*

2-Aminonaphthalene

Formaldehyde

NNN**

Ammonia

Nicotine (total and free)

 

Benzene

NNK*

 

Benzo[a]pyrene

NNN**

 

1,3-Butadiene

 

 

Carbon monoxide

 

 

Crotonaldehyde

 

 

Formaldehyde

 

 

Isoprene

 

 

Nicotine (total)

 

 

NNK*

 

 

NNN**

 

 

Toluene

 

 

1 - Roll-your-own tobacco is defined in section 900(15) of the FD&C Act to mean “any tobacco product which, because of its appearance, type, packaging, or labeling, is suitable for use and likely to be offered to, or purchased by, consumers as tobacco for making cigarettes.” The term cigarette filler is not defined in the FD&C Act. For purposes of this draft guidance, we intend cigarette filler to mean the cut, ground, powdered, or leaf tobacco that is a component of a cigarette.

*4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

** N-nitrosonornicotine

 

 

 

 

Contact FDA

1-877-CTP-1373
1-877-287-1373
(9am EST-4pm EST)
Tobacco

For General Inquiries:
AskCTP@fda.hhs.gov

Center for Tobacco Products Food and Drug Administration

10903 New Hampshire Avenue

Building 71, Room G335

Silver Spring, MD 20993-0002